ImmuCell Corp. (ICCC)
9.84
-0.06
(-0.61%)
USD |
NASDAQ |
Sep 08, 16:00
ImmuCell Total Assets (Quarterly) : 46.63M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.63M |
| March 31, 2026 | 44.11M |
| December 31, 2025 | 42.53M |
| September 30, 2025 | 45.73M |
| June 30, 2025 | 46.72M |
| March 31, 2025 | 45.62M |
| December 31, 2024 | 45.10M |
| September 30, 2024 | 44.45M |
| June 30, 2024 | 41.86M |
| March 31, 2024 | 43.05M |
| December 31, 2023 | 43.81M |
| September 30, 2023 | 44.54M |
| June 30, 2023 | 44.01M |
| March 31, 2023 | 43.12M |
| December 31, 2022 | 44.86M |
| September 30, 2022 | 46.40M |
| June 30, 2022 | 45.98M |
| March 31, 2022 | 46.70M |
| December 31, 2021 | 44.47M |
| September 30, 2021 | 44.23M |
| June 30, 2021 | 43.73M |
| March 31, 2021 | 39.62M |
| December 31, 2020 | 40.35M |
| September 30, 2020 | 39.99M |
| June 30, 2020 | 40.66M |
| Date | Value |
|---|---|
| March 31, 2020 | 40.05M |
| December 31, 2019 | 38.69M |
| September 30, 2019 | 38.85M |
| June 30, 2019 | 39.41M |
| March 31, 2019 | 40.48M |
| December 31, 2018 | 32.73M |
| September 30, 2018 | 33.24M |
| June 30, 2018 | 32.74M |
| March 31, 2018 | 33.63M |
| December 31, 2017 | 34.30M |
| September 30, 2017 | 30.29M |
| June 30, 2017 | 28.06M |
| March 31, 2017 | 25.33M |
| December 31, 2016 | 24.70M |
| September 30, 2016 | 20.58M |
| June 30, 2016 | 20.57M |
| March 31, 2016 | 20.38M |
| December 31, 2015 | 14.60M |
| September 30, 2015 | 14.22M |
| June 30, 2015 | 11.24M |
| March 31, 2015 | 11.23M |
| December 31, 2014 | 11.05M |
| September 30, 2014 | 10.74M |
| June 30, 2014 | 10.77M |
| March 31, 2014 | 11.12M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.26M |
| Shareholders Equity (Quarterly) | 31.37M |
| Debt to Equity Ratio | 0.3967 |
| Current Ratio | 4.752 |
| Net Debt Paydown Yield | 0.48% |